These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26119306)

  • 41. [Effect of active component compound of Epimedii Folium,Astragali Radix,and Puerariae Lobatae Radix on expression of ADAM17 in HT22 cells by mediating hepcidin].
    Dong XH; He XP; Zhang TC; Ma DX; Li JQ; Liu XX; Li H; Gao WJ
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6224-6230. PubMed ID: 34951249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual roles for autophagy: degradation and secretion of Alzheimer's disease Aβ peptide.
    Nilsson P; Saido TC
    Bioessays; 2014 Jun; 36(6):570-8. PubMed ID: 24711225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alzheimer's Disease in the Down Syndrome: An Overview of Genetics and Molecular Aspects.
    Gomes FC; Mattos MF; Goloni-Bertollo EM; Pavarino ÉC
    Neurol India; 2021; 69(1):32-41. PubMed ID: 33642267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Metalloproteinase Cocktail from the Venom of
    Futai E; Kawasaki H; Sato S; Daoudi K; Hidaka M; Tomita T; Ogawa T
    Toxins (Basel); 2023 Aug; 15(8):. PubMed ID: 37624257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory effects of Bombusae concretio Salicea on neuronal secretion of Alzheimer's beta-amyloid peptides, a neurodegenerative peptide.
    Jeong JC; Kang SK; Yoon CH; Seo YJ; Hwang CW; Ko JH; Lee YC; Chang YC; Kim CH
    Neurochem Res; 2003 Dec; 28(12):1785-92. PubMed ID: 14649718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Status update on iRhom and ADAM17: It's still complicated.
    Düsterhöft S; Babendreyer A; Giese AA; Flasshove C; Ludwig A
    Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1567-1583. PubMed ID: 31330158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Importance of GPCR-Mediated Microglial Activation in Alzheimer's Disease.
    Haque ME; Kim IS; Jakaria M; Akther M; Choi DK
    Front Cell Neurosci; 2018; 12():258. PubMed ID: 30186116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microglial polarization: novel therapeutic mechanism against Alzheimer's disease.
    Yao K; Zu HB
    Inflammopharmacology; 2020 Feb; 28(1):95-110. PubMed ID: 31264132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease.
    Hartl D; May P; Gu W; Mayhaus M; Pichler S; Spaniol C; Glaab E; Bobbili DR; Antony P; Koegelsberger S; Kurz A; Grimmer T; Morgan K; Vardarajan BN; Reitz C; Hardy J; Bras J; Guerreiro R; Balling R; Schneider JG; Riemenschneider M;
    Mol Psychiatry; 2020 Mar; 25(3):629-639. PubMed ID: 29988083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does Inflammation Play a Major Role in the Pathogenesis of Alzheimer's Disease?
    Wiatrak B; Jawień P; Szeląg A; Jęśkowiak-Kossakowska I
    Neuromolecular Med; 2023 Sep; 25(3):330-335. PubMed ID: 37027081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional Characterization of Colon Cancer-Associated Mutations in
    Pavlenko E; Cabron AS; Arnold P; Dobert JP; Rose-John S; Zunke F
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs.
    Medrano-Jiménez E; Meza-Sosa KF; Urbán-Aragón JA; Secundino I; Pedraza-Alva G; Pérez-Martínez L
    J Leukoc Biol; 2022 Jul; 112(1):47-77. PubMed ID: 35293018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The metalloprotease ADAM17 in inflammation and cancer.
    Düsterhöft S; Lokau J; Garbers C
    Pathol Res Pract; 2019 Jun; 215(6):152410. PubMed ID: 30992230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microglia and immunotherapy in Alzheimer's disease.
    Li Q; Wu Y; Chen J; Xuan A; Wang X
    Acta Neurol Scand; 2022 Mar; 145(3):273-278. PubMed ID: 34779509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Control of ADAM17 activity by regulation of its cellular localisation.
    Lorenzen I; Lokau J; Korpys Y; Oldefest M; Flynn CM; Künzel U; Garbers C; Freeman M; Grötzinger J; Düsterhöft S
    Sci Rep; 2016 Oct; 6():35067. PubMed ID: 27731361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Connection between periodontitis and Alzheimer's disease: possible roles of microglia and leptomeningeal cells.
    Wu Z; Nakanishi H
    J Pharmacol Sci; 2014; 126(1):8-13. PubMed ID: 25168594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroinflammation, immune system and Alzheimer disease: searching for the missing link.
    Guerriero F; Sgarlata C; Francis M; Maurizi N; Faragli A; Perna S; Rondanelli M; Rollone M; Ricevuti G
    Aging Clin Exp Res; 2017 Oct; 29(5):821-831. PubMed ID: 27718173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Zinc metalloproteinases and amyloid Beta-Peptide metabolism: the positive side of proteolysis in Alzheimer's disease.
    Gough M; Parr-Sturgess C; Parkin E
    Biochem Res Int; 2011; 2011():721463. PubMed ID: 21152187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Mechanism of Two Benzaldehydes from
    Chen M; Liang J; Liu Y; Liu Y; Zhou C; Hong P; Zhang Y; Qian ZJ
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation.
    Moss ML; Minond D
    Mediators Inflamm; 2017; 2017():9673537. PubMed ID: 29230082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.